Asia medical malpractice, clinical trials cover primed to grow
September 16 2021 by Andrew Tjaardstra
-
Asia firmly in Markel’s sights as it seeks to ‘equip, empower’ amid global leadership shake up
- May 7
Lloyd’s underwriter continues the hunt for an Asia Pacific CEO to succeed Christian Stobbs, who is returning to the UK.
-
Australia’s 1688 Underwriting gains Lloyd’s coveholder approval
- April 29
Sydney-based MGA can act as an agent for Lloyd’s syndicates in Australia.
-
Canopius appoints Andrew Ziolkowski to lead ANZ
- April 14
He succeeds Craig Elliot, who has served as interim head of the Australia business since December 2024.
-
London market ‘dismayed’ as Blueprint 2 testing delay could stretch to 2027
- April 11
Leading figures backed the move to push back the transformational initiative, but one leading figure tells InsuranceAsia News the implementation could go beyond next year.
-
HSBC Asset Management | China’s underestimated innovation capability – AI and beyond
DeepSeek’s breakthrough in artificial intelligence (AI) has gained a considerable amount of investor attention, lifting sentiment towards Chinese assets. We believe China’s innovation ability is not limited to AI.
-
Beazley | Turbulent Waters: The maritime energy transition challenges
Turbulent Waters: The maritime energy transition challenges
-
Aon | Navigating shifts in the global and Asia insurance markets
Neelay Patel, Aon head of growth for Asia, says the market in Asia is at an ‘interesting stage of the cycle’.
-
Sompo | Accelerating Sompo Group’s sustainable growth through the evolution of the P&C business
Sompo Holdings is taking significant steps to enhance its organizational structure and business strategy to achieve its ambition to become a Japan-born truly global company.
